Enclosed herewith Financial Results for the Quarter and Year ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Daikaffil Chemicals reported revenue from operations of ₹749.75 lacs for FY25 versus no reported operating revenue in FY24, suggesting commencement of commercial operations during the year. Total income for FY25 stood at ₹796.60 lacs but the company posted a net loss of ₹158.93 lacs (slightly narrower than FY24's loss of ₹190.22 lacs), translating to a loss per share of ₹2.65. The Board also appointed M/s. GMJ & Associates as Secretarial Auditor for five years and SPSJ & Associates LLP as Internal Auditor for FY26. The statutory auditor Natvarlal Vepari & Co LLP issued an unmodified opinion, while the FY24 comparatives were audited by the predecessor firm M/s. NGST & Associates.
The company remains loss-making with negative operating cash flow of ₹629.93 lacs, largely driven by a sharp jump in trade receivables (₹606 lacs) and inventory buildup, which has drained cash reserves from ₹751.91 lacs to just ₹66 lacs. While the loss is narrowing and operations have clearly begun, shareholders should monitor liquidity and working capital closely given the weak cash position and ongoing losses.